Cardiogenic Shock
210
62
70
61
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Research Maturity
61 completed trials (29% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
3.3%
7 terminated out of 210 trials
89.7%
+3.2% vs benchmark
10%
22 trials in Phase 3/4
8%
5 of 61 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 61 completed trials
Clinical Trials (210)
Augmented Pacing for Shock in the Cardiac Intensive Care Unit
Transcatheter Mitral Valve Repair for Inotrope Dependent Cardiogenic Shock
Platelet Function and Impella Support
Catheter-Oriented Unloading and Recovery With a Left Ventricular Assist Gear: Efficacy in Post Cardiotomy Cardiogenic Shock
Assessing Catecholamine Treatment Initiation Options: Norepinephrine vs Dopamine for Cardiogenic Shock
Physiology of Unloading VA ECMO Trial
INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recovery
Transcatheter AortiC Valve Implantation in aorTic stenosIs CardiogenIc Shock
Venous Oxygen Saturation During ECMO Support
Can Escalation Reduce Acute Myocardial Infarction Mortality in Cardiogenic Shock
Altshock-2 REGISTRY
Prolonged Nasogastric Administration of Ketones in Decompensated Heart Failure
Personalisation of Mean Arterial Pressure in Adult Patients With Cardiogenic Shock
Characterisation of phenotYpes in aCute Heart faiLure patiEnts
Clinical Outcome and Cost-effectiveness of Reduced Noradrenaline by Using a Lower Blood Pressure Target in Patients With Cardiogenic Shock From Acute Myocardial Infarction
Routine Versus Provisional Distal Perfusion Catheter Placement in Patients Undergoing Mechanical Circulatory Support
Evaluation of Acid-base Disorders and Ventilation Settings in Cardiogenic Shock and Post-cardiac Arrest Patients: Comparison With VentilO Algorithm
Multi-center Collaborative to Enhance Quality and Outcomes in the Management of Cardiogenic Shock
Inova Cardiogenic Shock Registry (INOVA SHOCK)
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial